Trial Profile
A Phase 2b, Multi-center, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets on HbA1c in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2021
Price :
$35
*
At a glance
- Drugs Bexagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Theracos
- 12 Jul 2016 Status changed from active, no longer recruiting to completed.
- 19 Feb 2016 Planned primary completion date changed from 1 May 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 19 Feb 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.